Loading…
Loading…
EQUITY / NASDAQ · XNMS
Turn Therapeutics Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗13.07 USD · -1.9505%
Observed: Oct 2, 2026, 9:17 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 13.33 USD · Volume 136,310
248 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -1,628,060 USD | -1,366,524 USD | — |
| Net income | -5,849,734 USD | -1,240,415 USD | — |
| Cash and cash equivalents | 9,948,952 USD | — | — |
| Total liabilities | 16,273,831 USD | — | — |
| Total equity | 686,888 USD | 1,774,496 USD | -61.29% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 101/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 9,948,952 USD | — | 11,009,553 USD | 4,027,862 USD | 4,027,862 USD | 513,695 USD | — | — |
| Net incomeIncome statement | -5,849,734 USD | -6,820,865 USD | -970,972 USD | — | -3,194,080 USD | -1,904,184 USD | -3,473,150 USD | -1,240,415 USD |
| Operating profitIncome statement | -1,628,060 USD | -2,842,823 USD | -1,246,143 USD | — | -5,858,648 USD | -1,913,555 USD | -3,665,078 USD | -1,366,524 USD |
| Total assetsBalance sheet | 16,960,719 USD | — | 18,644,136 USD | 12,162,241 USD | 12,162,241 USD | 4,297,630 USD | — | — |
| Total equityBalance sheet | 686,888 USD | — | 6,117,548 USD | 4,686,723 USD | 4,686,723 USD | 504,019 USD | — | 1,774,496 USD |
| Total liabilitiesBalance sheet | 16,273,831 USD | — | 12,526,588 USD | 7,475,518 USD | 7,475,518 USD | 3,793,611 USD | — | — |
| Financing cash flowCash flow statement | — | 7,786,562 USD | 7,786,561 USD | — | 6,919,432 USD | — | 3,741,736 USD | — |
| Investing cash flowCash flow statement | — | -18,025 USD | -12,227 USD | — | -152,986 USD | — | -121,545 USD | — |
| Operating cash flowCash flow statement | — | -2,556,171 USD | -1,632,807 USD | — | -2,562,901 USD | — | -1,386,634 USD | — |
| Report source | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 05/11/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/12/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.